ArticleImmunologic research2023

[Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer.

Linfeng Luo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.